Indiana Telemedicine Ban (HB 1533)
This law was last updated on Dec 5, 2014
HB 1533 would have prohibited knowingly dispensing abortion-inducing drugs by anyone other than a physician and would have required that the physician follow the drug label protocol for the abortion-inducing drug.
Before dispensing an abortion-inducing drug, a licensed physician must do the following:
- Examine the patient in person;
- Document the gestational age and intrauterine location of the fetus in the patient’s medical chart;
- provide a copy of the drug label, the physician’s telephone number and name of the hospital where the physician has admitting privileges as required in Indiana Code section 16-34-2-4.5;
- Provide the information contained in Indiana Code section 16-34-2-1.1.
The bill also would have required the physician to make reasonable efforts to ensure that the patient returns for a follow-up visit 14 days after the administration or use of the drug, and to document such efforts by including in the woman’s medical record the date, time, and name of the person making the effort.
The bill would have required physicians to report adverse events after a medication abortion to the FDA through the MedWatch Reporting System and to the medical licensing board of Indiana not later than three days following the physician’s knowledge of the adverse event third day after the date the physician learns of the occurrence.